A new study has demonstrated the antibiotic efficacy of cannabidiol, a non-psychoactive molecule extracted from Cannabis sativaDon't store avocado like this: it's dangerous
A new study found that the cannabidiol è active against Gram-positive bacteria resistant to other antibiotics. The new research opens the doors to new possible therapeutic uses of CBD, a molecule already studied to treat anxiety and inflammation and used in some forms of epilepsy.
The antibiotic action of Cannabidiol
New research has found that CBD oil is active against Gram-positive bacteria, including Staphyloccocus aureus and Streptococcus pneumoniae, responsible for many even severe infections.
In the study, cannabidiol appears to have demonstrated one potency similar to that of well-established antibiotics eat vancomycin or daptomycin.
The work was led by Dr Mark Blaskovich of the University of Queensland's Institute of Molecular Bioscience's Center for Superbug Solutions.
The research was carried out in collaboration with Botanix Pharmaceuticals Ltd, a company that studies the topical use of cannabidiol for skin disorders.
In this new study a drug containing cannabidiol was used, and the particularly interesting aspect that emerged from the experimentation is that the drug maintained its activity against bacteria highly resistant to other commonly used antibiotics. In fact, cannabidiol would be able to destroy the biofilm produced by bacteria, which makes it difficult to treat infections.
Furthermore, cannabidiol did not lose efficacy in prolonged use, as it happens in the treatment with other antibiotics.
Dr. Blaskovich pointed out that:
“Given cannabidiol's documented anti-inflammatory effects, existing human safety data and potential use as an antibiotic, this molecule deserves further investigation. The combination of antimicrobial and inflammatory activities in infections make cannabidiol particularly interesting. "
Il cannabidiol (CBD) is a cannabinoid found in Cannabis sativa and is one of the main ones non-psychoactive compounds that can be extracted from the hemp plant.
Currently, the administration of CBD is approved by the FDA to treat some forms of epilepsy.
The use of CBD was already studied for various pathologies and disorders, including anxiety, pain and inflammation and today it seems to have also demonstrated an antibiotic action.
The new research was presented on June 23 at ASM Microbe, the annual conference of the American Society for Microbiology.
- Cannabis: Cannabidiol (CBD) can reduce the risk of psychosis. I study
- Cdb Oil: all the health and beauty benefits of cannabis extracted oil
- Medical cannabis: everything you need to know
- Cannabis: the greenhouse in the UK where an anti-schizophrenia treatment is being studied